Company
Abbott Molecular Inc.
Use
Prognosis of breast cancer (in conjunction with other clinical data)
Features
First NIH licensed technology in an FDA approved product to be used in personalized medicine
NIH Contribution
Connection of HER2 gene with breast cancer.